Canada
BioNxt Solutions is a Canadian startup focused on accelerating innovation in drug delivery, diagnostics, and phytotherapeutics. Founded in 2018, the company aims to capitalize on the next generation of investment opportunities in the health care and pharmaceutical industries. With a slogan of "Accelerating innovation to impact," BioNxt offers investment opportunities in precision transdermal and oral dissolvable drug dosage forms, rapid, low-cost point-of-care infectious disease screening tools, and standardized and clinically-validated plant-based active pharmaceutical ingredients, primarily targeting European markets.
The company's most recent investment round saw a $1.17 million post-IPO equity investment on 28 December 2023. With a strong emphasis on cutting-edge solutions and a stated focus on impactful innovation, BioNxt Solutions presents an intriguing investment potential in the rapidly evolving biomedical landscape.
